Cytarabine-containing product in parenteral dose form   714225009

SNOMED CT code


SNOMED code714225009
nameCytarabine-containing product in parenteral dose form
statusactive
date introduced2016-01-31
fully specified name(s)Product containing cytarabine in parenteral dose form (medicinal product form)
synonymsCytarabine-containing product in parenteral dose form
attributes - group0
Plays roleAntineoplastic therapeutic role   773879000
Has manufactured dose formParenteral dose form   385287007
attributes - group1
Has active ingredientCytarabine   387511003
parents
  • Product manufactured as parenteral dose form   440132002
  • Cytarabine-containing product   89265009
children
  • Cytarabine 1 g/10 mL solution for injection vial   769652005  removed: 2019-01-31
  • Cytarabine 100 mg/mL solution for injection vial   769653000  removed: 2019-01-31
  • Cytarabine 100mg/mL injection solution 10mL vial   326854000  removed: 2018-07-31
  • Cytarabine 100mg/mL injection solution 1mL vial   326853006  removed: 2018-07-31
  • Cytarabine 100mg/mL injection solution 20mL vial   326844004  removed: 2018-07-31
  • Cytarabine 100mg/mL injection solution 5mL vial   326843005  removed: 2018-07-31
  • Cytarabine 1g/vial powder for injection   400671003  removed: 2018-07-31
  • Cytarabine 2 g/20 mL solution for injection vial   769654006  removed: 2019-01-31
  • Cytarabine 20mg/mL injection solution 25mL vial   326849009  removed: 2018-07-31
  • Cytarabine 20mg/mL injection solution 5mL   326852001  removed: 2018-07-31
  • Cytarabine 2g/vial powder for injection   400761009  removed: 2018-07-31
  • Cytarabine 500 mg/25 mL solution for injection vial   769656008  removed: 2019-01-31
  • Cytarabine 500 mg/5 mL solution for injection vial   769655007  removed: 2019-01-31
  • Cytarabine 500mg/vial powder for injection   400646001  removed: 2018-07-31
  • Cytarabine liposomal 50mg/5mL injection 5mL vial   376645003  removed: 2018-07-31
  • Cytarabine only product in parenteral dose form   773370007
  • Cytarabine- and daunorubicin-containing product in parenteral dose form   1290602003
hierarchies
a selection of possible paths
SNOMED CT Concept   138875005
  Pharmaceutical / biologic product   373873005
    Medicinal product   763158003
      Product manufactured as parenteral dose form   440132002
        Cytarabine-containing product in parenteral dose form   714225009

SNOMED CT Concept   138875005
  Pharmaceutical / biologic product   373873005
    Medicinal product   763158003
      Medicinal product categorized by therapeutic role   763087004
        Antineoplastic agent   27867009
          Pyrimidine analog antineoplastic agent   108812001
            Cytarabine-containing product   89265009
              Cytarabine-containing product in parenteral dose form   714225009

ancestors
sorted most to least specific
  • Product manufactured as parenteral dose form   440132002
  • Cytarabine-containing product   89265009
  • Pyrimidine analog antineoplastic agent   108812001
  • Antineoplastic agent   27867009
  • Antimetabolite-containing product   58760003
  • Nitrogen and/or nitrogen compound-containing product   768700009
  • Medicinal product categorized by therapeutic role   763087004
  • Immunomodulator-containing product   108940007
  • Medicinal product categorized by structure   763760008
  • Medicinal product categorized by disposition   766779001
  • Medicinal product   763158003
  • Pharmaceutical / biologic product   373873005
  • SNOMED CT Concept   138875005
cpt crosswalks

Rules-based maps relating CPT® codes to and from SNOMED CT® clinical concepts.  Forward and backward mapping allows for easy transition between code sets. Map-A-Code crosswalk tool easily crosswalks multiple codes between the code sets.

Access to this feature is available in the following products:
  • CPT® to SNOMED Crosswalks

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.